#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Neurodermatitis Hyperphagia Cerebral arteriovenous malformation haemorrhagic Congenital hypotransferrinaemia Myeloid leukaemia B-cell lymphoma recurrent Non-Hodgkin's lymphoma refractory Neurotrophic keratopathy Non-Hodgkin's lymphoma unspecified histology indolent Deafness neurosensory Synovial sarcoma metastatic Hyperadrenocorticism Non-small cell lung cancer recurrent Head and neck cancer More trials…

    Learn about Rare Diseases

    KBG syndrome – Basic Information Sarcoma Medulloblastoma recurrent – Trials in Disease Alagille syndrome – Basic Information Lymphangiosarcoma Glomerulonephritis membranoproliferative – Life with Disease Haemophilia B without inhibitors – Life with Disease Hyperoxaluria – Trials in Disease Nephroblastoma – Trials in Disease Bronchopulmonary dysplasia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cinnarizine Tinzaparin Sodium Mrna-3210 Estradiol Hemihydrate Imiquimod ANTIMETABOLITES S-241656 Siremadlin Brexucabtagene Autoleucel Disodium Folinate Crn04894 Bms-986408 Lufepirsen Adrenaline Tartrate Ph. Eur. GSKVX000000034795 Mepacrine Glofitamab WEF-001 Atorvastatin Birtamimab More therapies…

    Learn about Your Condition

    Syphilis Device related infection Renal disorder Gastric cancer recurrent Malignant melanoma stage III Eructation Rectosigmoid cancer Adenocarcinoma pancreas Streptococcal infection Pseudoxanthoma elasticum Sarcoma Myocarditis post infection Mucopolysaccharidosis Vertigo Autoimmune haemolytic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Evaluation of Botulinum Toxin Injections for Women with Severe Primary Dysmenorrhea Unresponsive to First-Line Treatments

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France
  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany
  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Lactic Acid
    • Levocarnitine
    • Magnesium Chloride Hexahydrate
    Italy
  • Study on Pravastatin for Pregnant Patients with Preeclampsia or Intrauterine Growth Restriction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pravastatin Sodium
    Spain
  • Study on Corifollitropin Alfa and Follitropin Beta for Women with Infertility Undergoing Ovarian Stimulation with Medroxyprogesterone Acetate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Corifollitropin Alfa
    • Follitropin Beta
    Spain
  • Study on Ovarian Stimulation Using Follitropin Delta and Dydrogesterone for Women Donating Eggs

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dydrogesterone
    • Follitropin Delta
    Belgium
Previous Page
1 2 3 4 5 6 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!